CRISPR Therapeutics AG (NASDAQ:CRSP)

40.05
Delayed Data
As of Oct 21
 +2.14 / +5.64%
Today’s Change
22.22
Today|||52-Week Range
53.90
+40.18%
Year-to-Date
3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year
Oct 08 / MotleyFool.com - Paid Partner Content
Should Investors Buy or Sell Sangamo Therapeutics Right Now?
Oct 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close37.91
Today’s open38.21
Day’s range38.09 - 40.80
Volume771,953
Average volume (3 months)514,880
Market cap$2.1B
Data as of 4:00pm ET, 10/21/2019

Growth & Valuation

Earnings growth (last year)-101.56%
Earnings growth (this year)+2.29%
Earnings growth (next 5 years)--
Revenue growth (last year)-92.38%
P/E ratioNM
Price/Sales438.65
Price/Book4.97

Competitors

 Today’s
change
Today’s
% change
TLRYTilray Inc+1.07+5.01%
XNCRXencor Inc+1.17+3.34%
XLRNAcceleron Pharma Inc+0.38+0.90%
HALOHalozyme Therapeutic...+0.08+0.56%
Data as of 4:00pm ET, 10/21/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$3.1M
Annual profit (last year)-$165.0M
Net profit margin-5,281.08%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Zug, Zug

Forecasts